Downloads

  1. Unfiltered: The Great PFAS Debate 8/7/2025

    Explore the global concern over persistent “forever chemicals” linked to health and environmental risks, as well as learn about regulatory debates, global restrictions, and why urgent action is needed.

  2. Stories From The Field: Supporting Critical Steps In Fill And Finish 8/7/2025

    Explore the critical final step in drug development—formulation and filling—and discover expert strategies that can help streamline operations, reduce risk, and enhance efficiency.

  3. Secure Your Sensitive Drug Substances 8/7/2025

    Explore the risks of freeze and thaw cycles on biological products and how an advanced plate freezing platform protects sensitive molecules with precision and ease.

  4. Optimized Expression Systems For Increased Productivity 8/7/2025

    Discover innovative strategies to boost CHO DG44 cell line productivity, as well as explore optimized expression systems that enhance yield, stability, and efficiency in protein development.

  5. Expand Your Capabilities And Shorten Your Time-To-Clinic 8/7/2025

    Gain expert insights into cell line development for biologics commercialization. and learn how CLD services—from DNA to GMP Master Cell Bank—can accelerate your path to clinical success.

  6. Reducing Risk, Decreasing Timelines, And Optimizing Outcomes 8/7/2025

    Explore the challenges of cell line development (CLD) in biologics commercialization and discover how integrated solutions can streamline your strategy, reduce risks, and optimize outcomes.

  7. Heart-In-A-Jar Organ Model Earns Regulatory Respect After 25 Years In The Making 8/7/2025

    Aligned with new FDA support for new approach methodologies (NAMs), Ronald Li, Ph.D, and Kevin Costa, Ph.D., share their story of creating Novoheart's mini heart organ model and discuss its current use in clinical trials.

  8. Zero To Final Fill: How HUGEL Implemented Its First Single-Use Lines 8/6/2025

    As regulations tighten, biomanufacturers are adopting single-use tech to boost compliance, reduce labor, and streamline fill-finish operations from the ground up.

  9. Developing Small Molecule Therapeutics To Tackle Heart Failure In DMD Patients 8/6/2025

    A great deal of attention has been focused on development of genetic therapies to treat DMD. But Revidia Therapeutics is focusing on developing small molecule drugs.

  10. Optimizing CHO Cell Culture Using A Design Of Experiments Approach 8/6/2025

    Learn how researchers optimized CHO cell culture to boost IgG1 titer to 5.8 g/L and improve viability, which cut development time from 14 days to 12 while enhancing productivity.